Related Experiment Video
Updated: Aug 14, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Surveillance of drug induced diseases in children
K P Kushwaha1, R B Verma, Y D Singh
1Department of Pediatrics, B.R.D. Medical College, Gorakhpur.
Insights
Drug-induced diseases (DID) affected 1.004% of pediatric patients. Neonates were most affected, with Erythmatous maculopapular rashes being common, while aplastic anemia caused by Chloramphenicol was fatal.
Area of Science:
- Pediatric Pharmacology
- Clinical Toxicology
- Drug Safety in Children
Background:
- Drug-induced diseases (DID) represent a significant concern in pediatric healthcare.
- Understanding the incidence and patterns of DID is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the prevalence, clinical manifestations, and outcomes of drug-induced diseases in children under 14 years of age.
- To identify common offending agents and risk factors associated with DID in a pediatric population.
Main Methods:
- A two-year prospective hospital-based study involving 20,310 pediatric patients.
- Diagnosis of DID based on clinical presentation and drug exposure history.
- In-hospital intensive surveillance for children with severe reactions.
Main Results:
- A total of 204 (1.004%) pediatric patients were diagnosed with DID.
- DID was most prevalent in neonates (24.51%), with Erythmatous maculopapular rashes being the most common manifestation (67.12%).
- Thrombophlebitis was common in infants and older children (41.56%).
- Mortality rate was 4.41% (9 out of 204 cases).
- Aplastic anemia, exclusively linked to Chloramphenicol, had a 100% mortality rate (7 cases).
- Commonly implicated agents included baby powders, massage oils, ampicillin, co-trimoxazole, IV infusions, DPT, and measles vaccines.
Conclusions:
- Drug-induced diseases are a notable cause of morbidity in children, particularly neonates.
- Prompt identification and management of DID are essential to reduce mortality and improve pediatric patient care.
- Surveillance for adverse drug reactions, including those from common substances and vaccines, is critical in pediatric settings.
Abstract:
A hospital based prospective study on drug induced diseases (DID) in children below 14 years of age was done for a duration of two years. A total number of 20,310 patients were examined in pediatric department during this period, out of which 204 (1.004%) patients were diagnosed as DID. Children with severe reactions were admitted in pediatric ward for in hospital intensive surveillance. The male:female ratio in DID was 1.2:1. DID were most common in neonates (24.51%). Erythmatous maculopapular rashes (67.12%) formed the most common pool of DID in neonates. Thrombophlebitis (41.56%) was most commonly seen in infants above 28 days of life, and in children up to 14 years of age. Out of 204 cases of DID, 9 (4.41%) died. Aplastic anemia was most morbid DID, as all the 7 patients of aplastic anemia died. Chloramphenicol was responsible for all the cases of aplastic anemia. Other two deaths were from erythma multiforme and C.C.F. The most commonly involved drugs, other substances and vaccines were baby powders, massage oils, ampicillin, co-trimoxazole, i.v. infusions (electrolytes and mannitol), DPT and measles vaccines.
More Related Videos
Related Concept Videos
Drug Regulation
Factors Affecting Drug Response: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmaceutical Poisoning: Potential Scenarios

